We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

120 hedge funds and large institutions have $657M invested in NovaBridge Biosciences American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 58 increasing their positions, 22 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 22

0.14% more ownership

Funds ownership: 21.79%21.93% (+0.14%)

9% less funds holding

Funds holding: 132120 (-12)

36% less call options, than puts

Call options by funds: $3.45M | Put options by funds: $5.36M

39% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 28

40% less funds holding in top 10

Funds holding in top 10: 106 (-4)

64% less capital invested

Capital invested by funds: $1.83B → $657M (-$1.17B)

Holders
120
Holders Change
-12
Holders Change %
-9.09%
% of All Funds
1.89%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
17
Increased
58
Reduced
22
Closed
28
Calls
$3.45M
Puts
$5.36M
Net Calls
-$1.91M
Net Calls Change
-$2.33M
Name Holding Trade Value Shares
Change
Change in
Stake
HA
1
HHLR Advisors
Cayman Islands
$117M
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$87.6M -$50.1M -1,953,615 -27%
BlackRock
3
BlackRock
New York
$55.3M +$24.1M +938,531 +38%
CC
4
Cederberg Capital
United Kingdom
$36M -$2.71M -105,885 -5%
Morgan Stanley
5
Morgan Stanley
New York
$26.4M +$4.26M +166,052 +11%
Artisan Partners
6
Artisan Partners
Wisconsin
$23.1M +$26M +1,016,180 +252%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$22.7M
OCA
8
Octagon Capital Advisors
New York
$17M
Vanguard Group
9
Vanguard Group
Pennsylvania
$16.3M +$762K +29,729 +3%
Bank of America
10
Bank of America
North Carolina
$14.2M +$2.77M +107,996 +14%
AG
11
Artal Group
Luxembourg
$13.8M
State Street
12
State Street
Massachusetts
$12.2M +$3.28M +127,890 +21%
Assenagon Asset Management
13
Assenagon Asset Management
Luxembourg
$12.1M +$10.4M +405,497 +119%
Goldman Sachs
14
Goldman Sachs
New York
$11.8M +$9.23M +360,273 +98%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
15
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$11M +$9.27M +361,700 +114%
Canada Pension Plan Investment Board
16
Canada Pension Plan Investment Board
Ontario, Canada
$10M +$3.74M +146,000 +31%
IAMH
17
IvyRock Asset Management (HK)
Hong Kong
$9.96M +$15.7M +613,356 New
Temasek Holdings
18
Temasek Holdings
Singapore
$9.2M
Two Sigma Investments
19
Two Sigma Investments
New York
$8.7M +$10.7M +417,060 +352%
Manulife (Manufacturers Life Insurance)
20
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$7.79M +$38.4K +1,500 +0.3%
EFM
21
E Fund Management
China
$7.01M +$1.18M +46,050 +12%
Principal Financial Group
22
Principal Financial Group
Iowa
$5.5M -$8.29M -323,615 -49%
PAMS
23
Pictet Asset Management (Switzerland)
Switzerland
$5.33M -$17.8M -695,825 -68%
BA
24
Bridgewater Associates
Connecticut
$5.07M +$3.24M +126,384 +68%
BS
25
Banco Santander
Spain
$4.87M +$7.69M +300,000 New

NBP Hedge Fund Activity: Q1 2022 in Review

120 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2022, worth a combined $657M — down 64% from $1.83B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NBP and 17 opened new positions — a net loss of 11 holders — while 22 trimmed existing stakes and 58 added.

The largest buyer was Artisan Partners, adding an estimated $26M. The largest seller was T. Rowe Price Associates, cutting an estimated $50.1M.

  • 120 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2022, down from 132 in Q4 2021.
  • Funds reported $657M of NovaBridge Biosciences American Depositary Shares stock for Q1 2022, down 64% quarter-over-quarter.
  • 17 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2022 and 28 closed out, a net change of -11 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2022 was Artisan Partners, an estimated $26M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2022 was T. Rowe Price Associates, an estimated $50.1M sold.

Based on aggregated 13F filings for Q1 2022.